SHE/301047 (SHE/301047)

Shenzhen Stock Exchange: SHE/301047 · CNY

CN¥102

-7.25 (-6.7%)· Recorded snapshot

Market cap	14.5B
Revenue (ttm)	792M
Net income (ttm)	179.1M
EPS (ttm)	CN¥1.47
Shares out	121.6M
P/E (trailing)	68.9x
P/E (forward)	71.3x
Dividend	CN¥2.00 (1.97%)
Volume	7,460,210
Beta	0.65

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 792M
Net income (ttm): 179.1M
EPS (ttm): CN¥1.47
P/E (trailing): 68.9x
P/E (forward): 71.3x
Market cap: 14.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E71.3

P25 n/aP50 n/aP75 n/a

Trailing P/E68.9

P25 n/aP50 n/aP75 n/a

ROE3.4

P25 n/aP50 n/aP75 n/a

ROIC5.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/301047 indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-27
Employees	1,069
Employees change	48
Employees growth	4.7%
Enterprise value	CNY 11.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	2016
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CNE100004Q23
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2022-03-30
Last stock split type	Forward
Market cap	CNY 14.5B
Next earnings date	2026-11-02
Price	CNY 101.50
Price currency	CNY
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	she/301047
Website	https://www.sinobiological.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	60.35x
Average P/E ratio (5Y)	52.5x
Earnings yield	1.45%
EV/Earnings	64.51x
EV/EBIT	79.54x
EV/EBITDA	48.74x
EV/FCF	210.47x
EV/Sales	14.59x
FCF / EV yield	0.48%
FCF yield	0.38%
Forward P/E	71.25x
Graham number	37.50809
Graham upside	-63.05%
Industry forward P/E	37.25x
Lynch fair value	CNY 7.36
Lynch upside	-92.75%
P/B ratio	2.8x
P/E ratio	68.94x
P/FCF ratio	263.7x
P/OCF ratio	67.54x
P/S ratio	18.27x
Price / tangible book value	2.97x
Price/EBITDA ratio	68.88x
Sector forward P/E	20.26x
Sector P/E	37.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.34%
EBITDA margin	26.53%
Effective tax rate	16.71%
FCF margin	6.93%
Gross margin	73.4%
Operating margin	18.34%
Pretax margin	27.14%
Profit margin	22.61%
Profit per employee	CNY 167,511
Revenue per employee	CNY 740,872
ROA	1.67%
ROA (5Y)	2.97%
ROCE	2.77%
ROE	3.43%
ROE (5Y)	6.25%
ROIC	5.51%
Tax / revenue	4.53%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	36.94%
EPS growth (Q)	32.55%
EPS growth (QoQ)	6.17%
EPS growth 3Y	-6.44%
EPS growth 5Y	-30.94%
FCF growth	26.61%
FCF growth (Q)	-61.01%
FCF growth (QoQ)	183.28%
FCF growth 5Y	-43.83%
Gross profit growth	22.42%
Gross profit growth (Q)	12.76%
Gross profit growth 3Y	5.43%
Gross profit growth 5Y	-14.62%
Net income growth	34.85%
Net income growth (Q)	32.54%
Net income growth (QoQ)	6.17%
Net income growth 3Y	-8.3%
Net income growth 5Y	-28.12%
OCF growth	75.51%
OCF growth (Q)	9.63%
OCF growth (QoQ)	27.73%
OCF growth 3Y	-5.77%
OCF growth 5Y	-26.65%
Operating income growth	165.19%
Operating income growth (Q)	61.78%
Operating income growth 3Y	1.38%
Operating income growth 5Y	-32.97%
Revenue growth	19.97%
Revenue growth (Q)	12.83%
Revenue growth (QoQ)	0.72%
Revenue growth 3Y	8.48%
Revenue growth 5Y	-9.99%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -159.4M
Depreciation and amortization	CNY 64.9M
EBIT	CNY 145.2M
EBITDA	CNY 210.1M
EPS	CNY 1.47
FCF per share	CNY 0.45
Financing cash flow	CNY -296.5M
Free cash flow	CNY 54.9M
Gross profit	CNY 581.3M
Income taxes	CNY 35.9M
Investing cash flow	CNY 37.9M
Net borrowing	CNY -31.1M
Net cash flow	CNY -50.7M
Net income	CNY 179.1M
Operating income	CNY 145.2M
Revenue	CNY 792M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CNY 42.47
Debt / EBITDA	0.17
Debt / equity	0.01
Debt / FCF	0.75
Goodwill	CNY 261M
Interest coverage	222.99
Long-term assets	CNY 2.1B
Long-term liabilities	CNY 78.9M
Net cash (debt)	CNY 2.9B
Net cash / market cap	20.19%
Net cash growth	-8.98%
Net debt / EBITDA	-13.9
Net debt / equity	-0.57
Net debt / FCF	-53.23
Piotroski F-Score	6
Property, plant and equipment	CNY 894M
Shareholders' equity	CNY 5.2B
Tangible book value	CNY 4.9B
Tangible book value per share	CNY 40.05
Total assets	CNY 5.4B
Total cash	CNY 3B
Total debt	CNY 41.1M
Total liabilities	CNY 229.8M
WACC	7.81%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.15
Current assets	CNY 3.3B
Current liabilities	CNY 150.9M
Current ratio	21.73
Inventory turnover	2.82
Net working capital	CNY 177.3M
Quick ratio	21.05
Working capital	CNY 3.1B
Working capital turnover	0.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.52%
Dividend growth	-56%
Dividend growth (3Y)	3.23%
Dividend growth years	1
Dividend payment date	2026-09-21
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	CNY 2.00
Dividend yield	1.97%
Ex-dividend date	2026-09-21
FCF payout ratio	487.56%
Last dividend	CNY 1.00
Payout ratio	149.44%
Shareholder yield	3.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 85.77
1D price change	-6.67%
1M price change	-30.89%
1M total return	-30.89%
1W price change	-10.06%
1W total return	-10.06%
1Y price change	35.28%
1Y return CAGR	38.88%
1Y total return	38.85%
20-day SMA	CNY 127.78
200-day SMA	CNY 82.68
3M price change	47.1%
3M total return	48.4%
3Y price change	22.3%
3Y return CAGR	11.32%
3Y total return	37.97%
50-day SMA	CNY 116.47
50-day SMA vs 200-day SMA	50over200
52-week high	CNY 165.00
52-week high date	2026-09-30
52-week low	CNY 58.05
52-week low date	2026-06-22
5Y price change	-44.9%
5Y return CAGR	-8.18%
5Y total return	-34.74%
6M price change	39.85%
6M total return	43.54%
All-time high	CNY 368.10
All-time high date	2021-08-19
All-time low	CNY 53.51
All-time low date	2024-08-30
Average true range (ATR)	CNY 11.68
Average volume	9.7M
Beta (1Y)	0.78
Beta (2Y)	0.81
Beta (5Y)	0.65
Change from 52-week high	-38.48%
Change from 52-week low	74.85%
Change from all-time high	-72.43%
Change from all-time low	89.68%
Change from open	-6.37%
Day's gap	-0.32%
Dollar volume	CNY 757.2M
High price	CNY 108.75
Low price	CNY 101.40
Monthly RSI	60.43
Open price	CNY 108.40
Position in 52-week range	1.36%
Previous close	CNY 108.75
Price vs 150-day SMA	18.34%
Price vs 20-day SMA	-20.56%
Price vs 200-day SMA	22.77%
Price vs 50-day SMA	-12.85%
Relative volume	0.75
RSI	50.99
Sharpe ratio	1.09
Sharpe ratio (3Y)	0.46
Sortino ratio	2.17
Sortino ratio (3Y)	0.96
Volume	7.5M
Weekly RSI	58.42
YTD price change	50.15%
YTD total return	54.11%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43.3M
Shares change (QoQ)	0%
Shares change (YoY)	-1.52%
Shares held by insiders	55.81%
Shares held by institutions	2.46%
Shares outstanding	121.6M

Deeper analysis on SHE/301047

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/301047 report

Is a complete SHE/301047 research report available?

No complete published report is available for she/301047 (SHE/301047) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/301047 (SHE/301047)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/301047

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/301047 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/301047

Frequently asked questions